Live Breaking News & Updates on செரா ஆய்வகம்

Stay updated with breaking news from செரா ஆய்வகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CURE Pharmaceutical to Present at 2021 NobleCon17 on Tuesday, January 19 at 3pm EST/12pm PST


Press release content from Business Wire. The AP news staff was not involved in its creation.
CURE Pharmaceutical to Present at 2021 NobleCon17 on Tuesday, January 19 at 3pm EST/12pm PST
January 19, 2021 GMT
OXNARD, Calif. (BUSINESS WIRE) Jan 19, 2021
CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company’s Chief Executive Officer Rob Davidson will be presenting virtually at NobleCon17, Noble Capital Markets’ Seventeenth Annual Institutional Investor Conference, on Tuesday, January 19, at 3:00 p.m. EST.
ADVERTISEMENT
Davidson will discuss how CURE continues to develop its position as a global health and wellness leader through its recent acquisition of Sera Labs. He will also provide an update on CURE’s recently approved Investigational New Drug (IND) application for CUREfilm Blue™ int ....

United States , Kathryn Brown , Jonathan Berlent , Gary Zwetchkenbaum , Rob Davidson , Noble Capital Markets Inc , Plum Tree Consulting , Securities Exchange , Sera Lab , Holding Corp , Chief Executive Officer Rob Davidson , Investigational New Drug , Sera Labs , Noble Capital Market Conference , Noble Capital Markets , Capital Markets , Securities Act , Securities Exchange Act , Exchange Act , Licensing Contact , Business Wire , Corporate News , Products And Services , Health Care Industry , Pharmaceutical Manufacturing , Consumer Products And Services ,